REQUEST A DEMO
Total
USD $0.00
Search more companies

Medgistix Corporation (Philippines)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Medgistix Corporation Profile Updated: December 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The subject is engaged with the wholesale distribution of pharmaceuticals and related products, including drugs and druggists sundries, to retailers, hospitals, and other healthcare providers.

Headquarters
Lot 734 No. 9 Ocean Park Avenue, Sauyo
Quezon City; National Capital Region; Postal Code: 1116

Contact Details: Purchase the Medgistix Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Medgistix Corporation report to view the information.
Financial Auditors:
Purchase the Medgistix Corporation report to view the information.
Incorporation Date:
September 24, 2020
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Treasurer
Ownership Details
Purchase this report to view the information.
27.01%
Purchase this report to view the information.
18%
Purchase this report to view the information.
11.07%
Purchase this report to view the information.
11.07%
Purchase this report to view the information.
6.57%
Company Performance
Financial values in the chart are available after Medgistix Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
29.74%
Total operating revenue
29.74%
Operating Profit/Loss (EBIT)
62.3%
EBITDA
62.3%
Net Profit/Loss for the Period
62.3%
Total Assets
-5.26%
Total Equity
55.04%
Operating Profit Margin (ROS)
0.72%
Net Profit Margin
0.54%
Return on Equity (ROE)
1.79%
Quick Ratio
0.05%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?